December 07, 2025 a 01:00 pm

CNC: Fundamental Ratio Analysis - Centene Corporation

Centene Corporation Stock Analysis

Centene Corporation operates within the healthcare sector, servicing under-insured and uninsured individuals in the United States. With a mission to provide accessible healthcare services, the stock displays mixed fundamental signals warranting cautious optimism.

Fundamental Rating

Centene Corporation's fundamentals suggest moderate performance in key areas, placing it at a 'C+' rating.

Category Score Visualization
Discounted Cash Flow 5
Return on Equity 1
Return on Assets 1
Debt to Equity 1
Price to Earnings 1
Price to Book 4

Historical Rating

A comparison of current and previous ratings shows stability in most metrics with consistent overall performance.

Date Overall Score Discounted Cash Flow Return on Equity Return on Assets Debt to Equity Price to Earnings Price to Book
2025-12-05 2 5 1 1 1 1 4
- 0 5 1 1 1 1 4

Analysts Price Targets

Analyst targets indicate a trend towards stability, with consensus reflecting a buying opportunity.

High Low Median Consensus
$45 $38 $42 $42
Centene Corporation Stock Chart

Analysts Sentiments

The overwhelming majority of analysts recommend buying, reflecting a positive outlook.

Recommendation Count Visualization
Strong Buy 0
Buy 23
Hold 18
Sell 2
Strong Sell 0

Conclusion

Centene Corporation's stock enjoys a generally positive sentiment from analysts, with a consensus towards buying. Despite some weaknesses noted in fundamental ratings, the stability in historical data and analyst optimism highlight potential for future growth. Investors should, however, remain cautious of economic fluctuations impacting the healthcare sector. Overall, Centene's diversified healthcare offerings could represent a solid investment opportunity.